A cerebrovascular accident is a pathological entity with the vascular impairment of sudden
onset, which leads to the lowering of the level of consciousness, differentiating it into …

Background: Atrial fibrillation is a public health problem associated with a fivefold increased
risk of stroke or death. Analyzing costs is important when introducing new therapies and …

Objective: To analyze the total direct cost of anticoagulant therapies indicated for the chronic
treatment of patients with non-valvular atrial fibrillation (AF) and the acute treatment of …

Objective To analyze the cost-effectiveness and cost-utility of dabigatran compared with
warfarin in patients with nonvalvular atrial fibrillation with moderate to high risk of ischemic …

OBJECTIVE To summarize the available evidence on the issues in health economics related
to oral anticoagulation for stroke prevention in atrial fibrillation (AF) in the US. DATA …

Health care resources available for medical procedures, including pharmaceuticals, are
limited worldwide. Health economic evidence is now accepted as an essential component of …

Cost-Effectiveness of a Novel Treatment for Stroke Prevention in Patients with Atrial Fibrillation:
Results from an Early Econom Page 1 Cost-Effectiveness of a Novel Treatment for Stroke …

Introduction: Atrial fibrillation (AF) increases the risk of ischemic stroke 5‐fold and may not
only be responsible for as many as 15% of all strokes that occur but also for larger and more …

ABSTRACT CONTEXT AND OBJECTIVE: Randomized clinical trials have shown that the
new oral anticoagulants have at least similar impact regarding reduction of thromboembolic …

Background Previous investigations into the cost effectiveness of direct oral anticoagulants
only considered individual stroke risk but not bleed risk even though bleeding is an …